DFIN vs JAZZ · P/E 20, rev $429.7M vs P/E 1988, rev $2.28B
Donnelley Financial Solutions Inc (DFIN) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Donnelley Financial Solutions Inc (DFIN) is a software - application company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported DFIN revenue for 2026-06-30 was $429.7M. Net income was $69.9M. DFIN currently screens at market cap $1.69B and trailing P/E 20.2.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
DFIN currently screens at market cap $1.69B and trailing P/E 20.2. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the DFIN and JAZZ stock pages for the full models.
Not investment advice.